Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 4, 2021
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signalingSilvia Marchianò, Michele Biagioli, Rosalinda Roselli, et al.
Journal of Cellular Physiology|December 7, 2020
Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2Raffaella Belvedere, Elva Morretta, Emanuela Pessolano, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 28, 2024
High levels of soluble CD73 unveil resistance to BRAF inhibitors in melanoma cellsCaterina Giraulo, Lavinia Orlando, Elva Morretta, et al.
Journal for Immunotherapy of Cancer|March 11, 2022
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agentsRoberta Turiello, Mariaelena Capone, Elva Morretta, et al.
Obesity Surgery|May 10, 2019
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related ComorbiditiesStefano De Vuono, Maria Anastasia Ricci, Elisa Nulli Migliola, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|August 19, 2022
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signalingSilvia Marchianò, Michele Biagioli, Rosalinda Roselli, et al.
Biomacromolecules|October 27, 2025
PEGylation-Driven Remodeling of the Protein Corona on PLGA Nanoparticles: Implications for Macrophage RecognitionLucio Spinelli, Pasquale D'Anna, Elva Morretta, et al.
Scientific Reports|January 28, 2023
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASHSilvia Marchianò, Michele Biagioli, Elva Morretta, et al.
Pageof 6